| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281717 | Clinical Gastroenterology and Hepatology | 2013 | 10 Pages |
Abstract
Among patients with BE, increased levels of leptin and insulin resistance are associated with increased risk for EA, whereas increased levels of high-molecular-weight adiponectin is associated inversely with EA. These biomarkers might be used to determine cancer risk among patients with BE.
Keywords
T2DIDFHGDNSAIDHMWHDLAHAPPIhigh-density lipoproteinEsophageal adenocarcinomaHomeostatic model assessmentOverweightAmerican Heart AssociationBody massnonsteroidal anti-inflammatory drugInternational Diabetes FederationType 2 diabetes mellitushigh-grade dysplasiaCancer risk factorEsophageal cancerbody mass indexBMIconfidence intervalBarrett's esophagusProton pump inhibitorhazard ratioHOMAhigh molecular weight
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Catherine Duggan, Lynn Onstad, Sheetal Hardikar, Patricia L. Blount, Brian J. Reid, Thomas L. Vaughan,